Cracking the New National Drug Code Format

September 24, 2026 | 2:00PM–3:30PM ET | Live Webinar

Register Now Cracking the New National Drug Code Format September 24, 2026, 2:00-3:30PM ET | Live Webinar
BUY NOW FDA and Medical Product Oversight: Assessing Recent Changes Recorded June 25, 2025 | On-Demand Webinar

Overview

FDA’s final rule to transition the National Drug Code (NDC) from the current 10-digit format to a 12-digit format will have significant implications across the drug supply chain. In this webinar, experts will discuss what manufacturers, distributors, and other stakeholders need to know to prepare for the transition, including potential impacts on labeling and data retention. Attendees will gain practical insights to help identify challenges and navigate the seven-year period before the rule takes effect in March of 2033. 

$149

Members

$249

Non-Members

Speakers

FDA invited

Abha Kundi
Read Bio
Counsel, ArentFox Schiff

Victoria Pankovich
Read Bio
Manager, Regulatory Services, EAS Consulting Group

Moderated By Eric Marshall
Read Bio
Principal, Leavitt Partners, LLC

FDLI applies for CLE credits in Ohio and Virginia. These CLE approvals also may be honored by other states. The CLE credits will be posted as they are granted and registrants can request to be notified when approval is received.